ALDR
TD Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,709
| Closed | -$277K | – | 1443 |
|
|
2019
Q3 | $277K | Sell |
14,709
-160,955
| -92% | -$3.03M | ﹤0.01% | 1260 |
|
|
2019
Q2 | $2.07M | Sell |
175,664
-44,400
| -20% | -$523K | ﹤0.01% | 901 |
|
|
2019
Q1 | $3M | Buy |
220,064
+8,881
| +4% | +$121K | ﹤0.01% | 819 |
|
|
2018
Q4 | $2.17M | Buy |
211,183
+15,488
| +8% | +$159K | ﹤0.01% | 897 |
|
|
2018
Q3 | $3.26M | Buy |
195,695
+112,395
| +135% | +$1.87M | ﹤0.01% | 860 |
|
|
2018
Q2 | $1.32M | Buy |
83,300
+36,800
| +79% | +$581K | ﹤0.01% | 1060 |
|
|
2018
Q1 | $591K | Buy |
46,500
+1,500
| +3% | +$19.1K | ﹤0.01% | 1161 |
|
|
2017
Q4 | $515K | Buy |
45,000
+4,500
| +11% | +$51.5K | ﹤0.01% | 1185 |
|
|
2017
Q3 | $496K | Sell |
40,500
-2,200
| -5% | -$26.9K | ﹤0.01% | 1167 |
|
|
2017
Q2 | $489K | Buy |
42,700
+25,600
| +150% | +$293K | ﹤0.01% | 1187 |
|
|
2017
Q1 | $356K | Sell |
17,100
-3,100
| -15% | -$64.5K | ﹤0.01% | 1293 |
|
|
2016
Q4 | $420K | Buy |
20,200
+8,269
| +69% | +$172K | ﹤0.01% | 1226 |
|
|
2016
Q3 | $391K | Buy |
+11,931
| New | +$391K | ﹤0.01% | 1245 |
|